Published in J Biol Chem on May 27, 2010
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). J Biol Chem (2011) 1.02
Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene (2012) 0.98
Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem (2011) 0.97
Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem (2012) 0.96
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Front Immunol (2015) 0.93
Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes. J Biol Chem (2012) 0.93
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. Biomed Res Int (2014) 0.91
Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem Cell Biol (2013) 0.88
Divergent Temporal Expression of Hyaluronan Metabolizing Enzymes and Receptors with Craniotomy vs. Controlled-Cortical Impact Injury in Rat Brain: A Pilot Study. Front Neurol (2014) 0.88
Chain gangs: new aspects of hyaluronan metabolism. Biochem Res Int (2011) 0.85
Hyaluronan synthase 2 protects skin fibroblasts against apoptosis induced by environmental stress. J Biol Chem (2014) 0.84
Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model. Int J Cell Biol (2015) 0.83
Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells. J Biol Chem (2013) 0.82
Collagen VI and hyaluronan: the common role in breast cancer. Biomed Res Int (2014) 0.82
Hyaluronan Synthase: The Mechanism of Initiation at the Reducing End and a Pendulum Model for Polysaccharide Translocation to the Cell Exterior. Int J Cell Biol (2015) 0.82
Rab10-mediated endocytosis of the hyaluronan synthase HAS3 regulates hyaluronan synthesis and cell adhesion to collagen. J Biol Chem (2014) 0.81
A novel mutation of Hyaluronan synthase 2 gene in Chinese children with ventricular septal defect. PLoS One (2014) 0.81
Hyaluronan synthase 1: a mysterious enzyme with unexpected functions. Front Immunol (2015) 0.80
Biology and biotechnology of hyaluronan. Glycoconj J (2015) 0.79
Fluorescence resonance energy transfer (FRET) and proximity ligation assays reveal functionally relevant homo- and heteromeric complexes among hyaluronan synthases HAS1, HAS2, and HAS3. J Biol Chem (2015) 0.79
Regulated Hyaluronan Synthesis by Vascular Cells. Int J Cell Biol (2015) 0.78
Insights into the structure and function of membrane-integrated processive glycosyltransferases. Curr Opin Struct Biol (2015) 0.78
4-Methylumbelliferone Diminishes Catabolically Activated Articular Chondrocytes and Cartilage Explants via a Mechanism Independent of Hyaluronan Inhibition. J Biol Chem (2016) 0.75
The control and importance of hyaluronan synthase expression in palatogenesis. Front Physiol (2013) 0.75
Human Keratinocytes Respond to Extracellular UTP by Induction of Hyaluronan Synthase 2 Expression and Increased Hyaluronan Synthesis. J Biol Chem (2017) 0.75
CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. Matrix Biol (2016) 0.75
Hyaluronan synthase assembles hyaluronan on a [GlcNAc(β1,4)]n-GlcNAc(α1→)UDP primer and hyaluronan retains this residual chitin oligomer as a cap at the nonreducing end. Glycobiology (2017) 0.75
The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function. Oncogenesis (2017) 0.75
Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol (2003) 8.13
Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol (2004) 7.10
Hyaluronan. FASEB J (1992) 6.67
Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science (2007) 6.65
Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 6.47
Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem Sci (2003) 3.37
Hyaluronan synthases. J Biol Chem (1997) 2.76
Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem (2007) 2.05
Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem (1998) 1.96
Ubiquitin in trafficking: the network at work. Exp Cell Res (2008) 1.94
Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta (2004) 1.64
Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem (2007) 1.57
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol (2008) 1.52
Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J (1989) 1.49
Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer (2007) 1.38
Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment. J Biol Chem (2004) 1.34
Expression of human hyaluronan synthases in response to external stimuli. Biochem J (2000) 1.29
Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem (1996) 1.24
Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem (1998) 1.22
Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J (2001) 1.19
Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem (1997) 1.18
Purification and lipid dependence of the recombinant hyaluronan synthases from Streptococcus pyogenes and Streptococcus equisimilis. J Biol Chem (1999) 1.18
Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem (2005) 1.17
Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. Biochem Pharmacol (2004) 1.17
Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem (2003) 1.16
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J (1995) 1.09
Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol (2008) 1.09
Characterization of hyaluronan synthase from a human glioma cell line. Biochim Biophys Acta (1998) 1.09
Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J (2007) 1.08
Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. Biochem J (1992) 1.06
Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation. J Biol Chem (2003) 1.05
Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res (1993) 1.04
Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem (2007) 1.01
Intracellular signal transduction for serum activation of the hyaluronan synthase in eukaryotic cell lines. J Cell Physiol (1994) 0.99
Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J (2006) 0.95
Sample preparation by SDS/PAGE and in-gel digestion. EXS (2000) 0.94
Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem (2009) 0.91
Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J Invest Dermatol (2002) 0.91
Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochim Biophys Acta (2007) 0.87
Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. Wien Med Wochenschr (2006) 0.85
Human cytogenetic consequences of the Chernobyl accident. Mutat Res (1996) 0.82
'Piggy-back' transport of Xenopus hyaluronan synthase (XHAS1) via the secretory pathway to the plasma membrane. Biol Chem (2003) 0.81
Non-Smad TGF-beta signals. J Cell Sci (2005) 6.06
The regulation of TGFbeta signal transduction. Development (2009) 4.59
The genome sequence of silkworm, Bombyx mori. DNA Res (2004) 4.27
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci (2007) 4.07
TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell (2005) 3.75
Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques. Biophys J (2004) 3.54
Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol (2006) 3.44
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol (2008) 3.31
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res (2002) 2.70
PDGF receptors as cancer drug targets. Cancer Cell (2003) 2.66
The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem Biophys Res Commun (2006) 2.63
Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis. J Biol Chem (2002) 2.56
Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol (2004) 2.53
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol (2005) 2.32
Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell (2002) 2.27
Improvement in cognitive impairment after cataract surgery in elderly patients. J Cataract Refract Surg (2004) 2.24
HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem (2008) 2.22
Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell (2002) 2.18
A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat Genet (2008) 2.13
Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell (2003) 2.03
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol (2002) 2.01
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2005) 1.95
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol (2004) 1.92
Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem (2002) 1.89
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology (2003) 1.83
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol (2009) 1.81
The long-term effects of self-management education for patients with type 2 diabetes on glycemic control: response to Norris et al. Diabetes Care (2002) 1.78
PDGF receptors as targets in tumor treatment. Adv Cancer Res (2007) 1.76
Proteoglycan fragmentation and respiratory mechanics in mechanically ventilated healthy rats. J Appl Physiol (1985) (2007) 1.74
Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res (2004) 1.72
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest (2008) 1.68
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem (2005) 1.60
Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair. Genes Dev (2011) 1.60
Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica (2005) 1.59
RNA helicase A is a downstream mediator of KIF1Bβ tumor-suppressor function in neuroblastoma. Cancer Discov (2014) 1.58
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res (2011) 1.55
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest (2005) 1.55
Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol Cell Biol (2003) 1.50
Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med (2010) 1.48
Ninein is expressed in the cytoplasm of angiogenic tip-cells and regulates tubular morphogenesis of endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.48
Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res (2008) 1.45
Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol (2002) 1.45
Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol (2005) 1.44
Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study. J Atheroscler Thromb (2015) 1.44
The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. Mol Cell Biol (2006) 1.42
Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol (2005) 1.41
Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem (2004) 1.38
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol (2002) 1.36
Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol (2007) 1.36
Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol (2006) 1.36
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer (2007) 1.35
Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins. J Biol Chem (2004) 1.33
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology (2006) 1.33
Differential ubiquitination defines the functional status of the tumor suppressor Smad4. J Biol Chem (2003) 1.33
Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A (2004) 1.33
PARP-1 attenuates Smad-mediated transcription. Mol Cell (2010) 1.32
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood (2005) 1.29
TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun (2011) 1.28
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol (2003) 1.27
STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. Clin Cancer Res (2003) 1.27
Cup-shaped choroidal excavation detected by optical coherence tomography: a case report. Retin Cases Brief Rep (2010) 1.25
Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases. Exp Cell Res (2007) 1.25
Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res (2008) 1.25
The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem (2005) 1.24
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology (2008) 1.23
p53 targets identified by protein expression profiling. Proc Natl Acad Sci U S A (2007) 1.23
Induction of epithelial-mesenchymal transition by transforming growth factor β. Semin Cancer Biol (2012) 1.21
Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol (2005) 1.21
Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology (2005) 1.20
Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2004) 1.20
The role of proteoglycans in pulmonary edema development. Intensive Care Med (2008) 1.18
Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study. Ophthalmology (2006) 1.17
Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. J Biol Chem (2012) 1.16
Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. J Biol Chem (2008) 1.16
The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology (2009) 1.15
Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res (2005) 1.15
Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Int J Cancer (2007) 1.15
Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom. BMC Evol Biol (2009) 1.14
The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J Biol Chem (2006) 1.14
An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling. EMBO J (2008) 1.13
Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology (2011) 1.11
Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol (2005) 1.11
Proteome analysis of human vitreous proteins. Mol Cell Proteomics (2003) 1.11
Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J Biol Chem (2006) 1.10
Dynamic control of TGF-beta signaling and its links to the cytoskeleton. FEBS Lett (2008) 1.10
Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis is a sulfite reductase with a covalent Cys-Tyr bond in the active site. J Biol Chem (2005) 1.10
Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF. Biochem J (2003) 1.10
TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1. Cell Cycle (2014) 1.09
Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J (2007) 1.08
Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. Int J Cancer (2006) 1.07